Stay updated on Safety of Subcutaneous SHR-1209 in Hyperlipidemia Clinical Trial
Sign up to get notified when there's something new on the Safety of Subcutaneous SHR-1209 in Hyperlipidemia Clinical Trial page.

Latest updates to the Safety of Subcutaneous SHR-1209 in Hyperlipidemia Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe record history shows the site revision tag updated from v3.6.6 to v3.7.0, indicating a software release for the ClinicalTrials.gov interface.SummaryDifference0.1%

- Check36 days agoChange DetectedA new revision entry v3.6.6 was added to the study record history and the previous v3.6.5 entry was removed, updating the historical record to reflect the latest published version.SummaryDifference0.1%

- Check57 days agoChange DetectedA new revision entry v3.6.5 was added to the study record history, superseding the previous v3.6.4.SummaryDifference0.1%

- Check71 days agoChange DetectedRecord history includes a new revision entry v3.6.4, superseding v3.6.3. This reflects a minor metadata update to the page rather than changes to study data or content.SummaryDifference0.1%

- Check93 days agoChange DetectedThe record history now includes revision v3.6.3, replacing the previous v3.6.2. This indicates a minor update to the study record's metadata.SummaryDifference0.1%

- Check100 days agoChange DetectedThe record history now includes a new revision entry v3.6.2. The previous revision v3.6.0 was removed.SummaryDifference0.1%

Stay in the know with updates to Safety of Subcutaneous SHR-1209 in Hyperlipidemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Subcutaneous SHR-1209 in Hyperlipidemia Clinical Trial page.